Abstract
BackgroundWe aimed to assess whether whole blood expression quantitative trait loci (eQTLs) with effects in cis and trans are robust and can be used to identify regulatory pathways affecting disease susceptibility.Materials and MethodsWe performed whole-genome eQTL analyses in 890 participants of the KORA F4 study and in two independent replication samples (SHIP-TREND, N = 976 and EGCUT, N = 842) using linear regression models and Bonferroni correction.ResultsIn the KORA F4 study, 4,116 cis-eQTLs (defined as SNP-probe pairs where the SNP is located within a 500 kb window around the transcription unit) and 94 trans-eQTLs reached genome-wide significance and overall 91% (92% of cis-, 84% of trans-eQTLs) were confirmed in at least one of the two replication studies. Different study designs including distinct laboratory reagents (PAXgene™ vs. Tempus™ tubes) did not affect reproducibility (separate overall replication overlap: 78% and 82%). Immune response pathways were enriched in cis- and trans-eQTLs and significant cis-eQTLs were partly coexistent in other tissues (cross-tissue similarity 40–70%). Furthermore, four chromosomal regions displayed simultaneous impact on multiple gene expression levels in trans, and 746 eQTL-SNPs have been previously reported to have clinical relevance. We demonstrated cross-associations between eQTL-SNPs, gene expression levels in trans, and clinical phenotypes as well as a link between eQTLs and human metabolic traits via modification of gene regulation in cis.ConclusionsOur data suggest that whole blood is a robust tissue for eQTL analysis and may be used both for biomarker studies and to enhance our understanding of molecular mechanisms underlying gene-disease associations.
Highlights
The key aim of human genetics is to elucidate molecular mechanisms underlying phenotypic variation, with respect to disease and disease susceptibility [1]
EQTL mapping studies in whole blood have focused on genetic variation with an impact on gene regulation acting in trans to identify downstream mechanisms of these variants on clinical phenotypes or were restricted in sample size [2,3,4]
In a previous work conducted in 322 European subjects, we found that whole blood expression quantitative trait loci (eQTL) with effects in cis were reproducible, while the power to address this question for eQTLs with effects in trans was limited due to the burden of multiple testing [4]
Summary
The key aim of human genetics is to elucidate molecular mechanisms underlying phenotypic variation, with respect to disease and disease susceptibility [1]. Analysis of whole genome expression quantitative trait loci (eQTL) provide a means for detecting transcriptional regulatory relationships at a genome-wide scale and for identifying regulatory pathways affecting disease susceptibility [2]. EQTL mapping studies in whole blood have focused on genetic variation with an impact on gene regulation acting in trans to identify downstream mechanisms of these variants on clinical phenotypes or were restricted in sample size [2,3,4]. We aimed to assess whether whole blood expression quantitative trait loci (eQTLs) with effects in cis and trans are robust and can be used to identify regulatory pathways affecting disease susceptibility
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
